Daily Study

A lower session: SPY −0.38%, QQQ −1.19%

Three screens filtered 1,892 US stocks down to 12 names on this page: the top and the bottom of each ordering. 6 of 12 closed lower and 6 higher; small caps (IWM) moved −0.31%.

SPY−0.38%
S&P 500 ETF754.27
QQQ−1.19%
Nasdaq 100 ETF679.10
IWM−0.31%
Russell 2000 ETF277.55
DIA+0.12%
Dow 30 ETF523.10
names screened
1,892
studied in depth
145
on this page
12
screens
3

A record of what moved, not a recommendation.Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRLMethodologyDisclaimer

Each screen starts from a broad filter of US stocks; the candidates are then ordered by a combined fundamentals-and-trend read. The page shows the names at the top and at the bottom of that order, so you see both ends of the same filter, not a pick list. Open any case study for the session, the three-month trend and the latest SEC financials. IEX volume is only the share traded on IEX, so it is compared with its own 20-day average.

Learn more: Top and Bottom of the Screen: An Ordering, Not a Verdict · Where the Numbers Come From: IEX Prices and SEC Filings · Reading the Cash Flow Statement · Return on Equity and Leverage

504matched the screen
60studied in depth
4on this page

Top of the screen

CRCT

Cricut Inc

8.64+1.8%
TechnologyComputer Hardware
3 months+57.8%
52-week range52w low83%high
RSI (14)68
Session
above VWAP 8.581.16× avg vol
Moving averages
above 50dabove 200d
View CRCT chart on TradingView Affiliate
Case study: why CRCT is on this page

Top of this screen: profitable last fiscal year; revenue -0.5% YoY; above its 200-day average; +57.8% over 3 months.

Close 8.64: +1.8% vs previous closeSession (open→close): +0.5%

Session: day range 8.39–8.68, VWAP 8.58 (above VWAP), IEX volume 1.16× its 20-day average. Trend: +57.8% over three months, 83% of the way up its 52-week range, RSI(14) 68, above its 50-day and above its 200-day average.

Intraday chart of CRCT on 2026-11-13
Session (intraday)
Three-month daily chart of CRCT
Three months (daily)
Revenue (latest FY)
$708.8M
Net income (latest FY)
$76.7M
Cash
$174.6M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Cricut Inc filings on SEC EDGAR

EGHT

8X8 Inc

2.31−1.3%
TechnologySoftware - Application
3 months+13.5%
52-week range52w low58%high
RSI (14)58
Session
at VWAP 2.300.44× avg vol
Moving averages
above 50dabove 200d
View EGHT chart on TradingView Affiliate
Case study: why EGHT is on this page

Top of this screen: profitable last fiscal year; revenue +2.9% YoY; above its 200-day average.

Close 2.31: −1.3% vs previous closeSession (open→close): −0.9%

Session: day range 2.27–2.33, VWAP 2.30 (at VWAP), IEX volume 0.44× its 20-day average. Trend: +13.5% over three months, 58% of the way up its 52-week range, RSI(14) 58, above its 50-day and above its 200-day average.

Intraday chart of EGHT on 2026-11-13
Session (intraday)
Three-month daily chart of EGHT
Three months (daily)
Revenue (latest FY)
$735.8M
Net income (latest FY)
$1.6M
Cash
$101.7M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: 8X8 Inc filings on SEC EDGAR

Bottom of the screen

ARTV

Artiva Biotherapeutics Inc

4.01+0.9%
HealthcareBiotechnology
3 months−65.6%
52-week range52w low9%high
RSI (14)23
Session
above VWAP 3.980.74× avg vol
Moving averages
below 50dbelow 200d
View ARTV chart on TradingView Affiliate
Case study: why ARTV is on this page

Bottom of this screen: a net loss last fiscal year; revenue -100.0% YoY; below its 200-day average; near its 52-week low; -65.6% over 3 months.

Close 4.01: +0.9% vs previous closeSession (open→close): +0.1%

Session: day range 3.91–4.03, VWAP 3.98 (above VWAP), IEX volume 0.74× its 20-day average. Trend: −65.6% over three months, 9% of the way up its 52-week range, RSI(14) 23, below its 50-day and below its 200-day average.

Intraday chart of ARTV on 2026-11-13
Session (intraday)
Three-month daily chart of ARTV
Three months (daily)
Revenue (latest FY)
$0
Net income (latest FY)
−$83.9M
Cash
$61.2M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Artiva Biotherapeutics Inc filings on SEC EDGAR

SNDX

Syndax Pharmaceuticals Inc

9.45−0.9%
HealthcareBiotechnology
3 months−52.6%
52-week range52w low2%high
RSI (14)27
Session
above VWAP 9.340.67× avg vol
Moving averages
below 50dbelow 200d
View SNDX chart on TradingView Affiliate
Case study: why SNDX is on this page

Bottom of this screen: a net loss last fiscal year; revenue +627.8% YoY; below its 200-day average; near its 52-week low; -52.6% over 3 months.

Close 9.45: −0.9% vs previous closeSession (open→close): −1.0%

Session: day range 9.13–9.55, VWAP 9.34 (above VWAP), IEX volume 0.67× its 20-day average. Trend: −52.6% over three months, 2% of the way up its 52-week range, RSI(14) 27, below its 50-day and below its 200-day average.

Intraday chart of SNDX on 2026-11-13
Session (intraday)
Three-month daily chart of SNDX
Three months (daily)
Revenue (latest FY)
$172.4M
Net income (latest FY)
−$285.4M
Cash
$135.9M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Syndax Pharmaceuticals Inc filings on SEC EDGAR

1,363matched the screen
60studied in depth
4on this page

Top of the screen

FULT

Fulton Financial Corp

23.99+0.6%
FinancialBanks - Regional
3 months−1.3%
52-week range52w low85%high
RSI (14)58
Session
at VWAP 23.920.58× avg vol
Moving averages
above 50dabove 200d
View FULT chart on TradingView Affiliate
Case study: why FULT is on this page

Top of this screen: profitable last fiscal year; revenue -6.5% YoY; above its 200-day average.

Close 23.99: +0.6% vs previous closeSession (open→close): +0.4%

Session: day range 23.75–24.02, VWAP 23.92 (at VWAP), IEX volume 0.58× its 20-day average. Trend: −1.3% over three months, 85% of the way up its 52-week range, RSI(14) 58, above its 50-day and above its 200-day average.

Intraday chart of FULT on 2026-11-13
Session (intraday)
Three-month daily chart of FULT
Three months (daily)
Revenue (latest FY)
$276.8M
Net income (latest FY)
$391.6M
Cash
$1.11B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Fulton Financial Corp filings on SEC EDGAR

DXC

DXC Technology Co

14.73−0.7%
TechnologyInformation Technology Services
3 months+40.3%
52-week range52w low81%high
RSI (14)54
Session
below VWAP 14.850.31× avg vol
Moving averages
above 50dabove 200d
View DXC chart on TradingView Affiliate
Case study: why DXC is on this page

Top of this screen: profitable last fiscal year; revenue -1.8% YoY; above its 200-day average; +40.3% over 3 months.

Close 14.73: −0.7% vs previous closeSession (open→close): −0.9%

Session: day range 14.72–15.11, VWAP 14.85 (below VWAP), IEX volume 0.31× its 20-day average. Trend: +40.3% over three months, 81% of the way up its 52-week range, RSI(14) 54, above its 50-day and above its 200-day average.

Intraday chart of DXC on 2026-11-13
Session (intraday)
Three-month daily chart of DXC
Three months (daily)
Revenue (latest FY)
$12.64B
Net income (latest FY)
$18.0M
Cash
$1.60B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: DXC Technology Co filings on SEC EDGAR

Bottom of the screen

BEAM

Beam Therapeutics Inc

22.82−5.0%
HealthcareBiotechnology
3 months−14.1%
52-week range52w low14%high
RSI (14)40
Session
below VWAP 23.180.98× avg vol
Moving averages
below 50dbelow 200d
View BEAM chart on TradingView Affiliate
Case study: why BEAM is on this page

Bottom of this screen: a net loss last fiscal year; revenue +120.0% YoY; below its 200-day average.

Close 22.82: −5.0% vs previous closeSession (open→close): −4.6%

Session: day range 22.82–23.93, VWAP 23.18 (below VWAP), IEX volume 0.98× its 20-day average. Trend: −14.1% over three months, 14% of the way up its 52-week range, RSI(14) 40, below its 50-day and below its 200-day average.

Intraday chart of BEAM on 2026-11-13
Session (intraday)
Three-month daily chart of BEAM
Three months (daily)
Revenue (latest FY)
$139.7M
Net income (latest FY)
−$80.0M
Cash
$213.3M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Beam Therapeutics Inc filings on SEC EDGAR

GPCR

Structure Therapeutics Inc ADR

20.01+1.2%
HealthcareBiotechnology
3 months−62.6%
52-week range52w low2%high
RSI (14)34
Session
at VWAP 19.921.18× avg vol
Moving averages
below 50dbelow 200d
View GPCR chart on TradingView Affiliate
Case study: why GPCR is on this page

Bottom of this screen: a net loss last fiscal year; below its 200-day average; near its 52-week low; -62.6% over 3 months.

Close 20.01: +1.2% vs previous closeSession (open→close): +0.9%

Session: day range 19.11–20.45, VWAP 19.92 (at VWAP), IEX volume 1.18× its 20-day average. Trend: −62.6% over three months, 2% of the way up its 52-week range, RSI(14) 34, below its 50-day and below its 200-day average.

Intraday chart of GPCR on 2026-11-13
Session (intraday)
Three-month daily chart of GPCR
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$141.2M
Cash
$222.0M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Structure Therapeutics Inc ADR filings on SEC EDGAR

25matched the screen
25studied in depth
4on this page

Top of the screen

AAPL

Apple Inc

356.40+0.4%
TechnologyConsumer Electronics
3 months+14.9%
52-week range52w low96%high
RSI (14)61
Session
at VWAP 357.880.89× avg vol
Moving averages
above 50dabove 200d
View AAPL chart on TradingView Affiliate
Case study: why AAPL is on this page

Top of this screen: profitable last fiscal year; revenue +15.1% YoY; above its 200-day average; near its 52-week high.

Close 356.40: +0.4% vs previous closeSession (open→close): −0.4%

Session: day range 355.76–360.81, VWAP 357.88 (at VWAP), IEX volume 0.89× its 20-day average. Trend: +14.9% over three months, 96% of the way up its 52-week range, RSI(14) 61, above its 50-day and above its 200-day average.

Intraday chart of AAPL on 2026-11-13
Session (intraday)
Three-month daily chart of AAPL
Three months (daily)
Revenue (latest FY)
$478.83B
Net income (latest FY)
$132.18B
Cash
$36.30B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Apple Inc filings on SEC EDGAR

MU

Micron Technology Inc

778.31−2.6%
TechnologySemiconductors
3 months−17.3%
52-week range52w low55%high
RSI (14)42
Session
above VWAP 768.660.81× avg vol
Moving averages
below 50dabove 200d
View MU chart on TradingView Affiliate
Case study: why MU is on this page

Top of this screen: profitable last fiscal year; revenue +256.3% YoY; above its 200-day average; -17.3% over 3 months.

Close 778.31: −2.6% vs previous closeSession (open→close): −0.6%

Session: day range 750.35–795.79, VWAP 768.66 (above VWAP), IEX volume 0.81× its 20-day average. Trend: −17.3% over three months, 55% of the way up its 52-week range, RSI(14) 42, below its 50-day and above its 200-day average.

Intraday chart of MU on 2026-11-13
Session (intraday)
Three-month daily chart of MU
Three months (daily)
Revenue (latest FY)
$133.19B
Net income (latest FY)
$84.97B
Cash
$38.36B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Micron Technology Inc filings on SEC EDGAR

Bottom of the screen

ALNY

Alnylam Pharmaceuticals Inc

165.02+5.4%
HealthcareBiotechnology
3 months−27.8%
52-week range52w low5%high
RSI (14)35
Session
at VWAP 165.551.28× avg vol
Moving averages
below 50dbelow 200d
View ALNY chart on TradingView Affiliate
Case study: why ALNY is on this page

Bottom of this screen: profitable last fiscal year; revenue +65.2% YoY; below its 200-day average; near its 52-week low; -27.8% over 3 months.

Close 165.02: +5.4% vs previous closeSession (open→close): +3.5%

Session: day range 159.20–168.16, VWAP 165.55 (at VWAP), IEX volume 1.28× its 20-day average. Trend: −27.8% over three months, 5% of the way up its 52-week range, RSI(14) 35, below its 50-day and below its 200-day average.

Intraday chart of ALNY on 2026-11-13
Session (intraday)
Three-month daily chart of ALNY
Three months (daily)
Revenue (latest FY)
$3.71B
Net income (latest FY)
$313.7M
Cash
$1.75B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Alnylam Pharmaceuticals Inc filings on SEC EDGAR

NVDA

NVIDIA Corp

162.84−1.9%
TechnologySemiconductors
3 months−25.9%
52-week range52w low15%high
RSI (14)25
Session
above VWAP 161.561.46× avg vol
Moving averages
below 50dbelow 200d
View NVDA chart on TradingView Affiliate
Case study: why NVDA is on this page

Bottom of this screen: profitable last fiscal year; revenue +65.5% YoY; below its 200-day average; -25.9% over 3 months.

Close 162.84: −1.9% vs previous closeSession (open→close): −4.1%

Session: day range 158.40–169.98, VWAP 161.56 (above VWAP), IEX volume 1.46× its 20-day average. Trend: −25.9% over three months, 15% of the way up its 52-week range, RSI(14) 25, below its 50-day and below its 200-day average.

Intraday chart of NVDA on 2026-11-13
Session (intraday)
Three-month daily chart of NVDA
Three months (daily)
Revenue (latest FY)
$215.94B
Net income (latest FY)
$120.07B
Cash
$22.44B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NVIDIA Corp filings on SEC EDGAR

The charts use the candlestick, VWAP and moving-average reading taught in our free courses. To pull up any of these tickers yourself, TradingView’s free plan covers it. Affiliate link: we may earn a commission if you subscribe, at no extra cost to you.

Reminder: nothing on this page is investment advice. These names appear because of where they landed in the screen, not because of any view on where the price goes next. Past performance does not indicate future results. See the Disclaimer.